Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 FDA OKs VySpine's LumiVy Lumbar IBF with NanoVy Ti - Orthopedic Design & Technology
OEM News

FDA OKs VySpine’s LumiVy Lumbar IBF with NanoVy Ti

Indicated for intervertebral body fusion at one level or two contiguous levels in the lumbar spine, from L2 to S1.

Spine technology firm VySpine has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its LumiVy NanoVy Ti lumbar IBF system for intervertebral body fusion at one level or two contiguous levels in the lumbar spine, from L2 to S1, to treat degenerative disc disease (DDD) with up to Grade 1 spondylolisthesis.
 
LumiVy NanoVy features the company’s proprietary Ti coating, in partnership with Implant Surfaces. The titanium coating is nanometers thick and adhered to a PEEK (polyether-ether-ketone) LumiVy implant. The coating is designed to facilitate direct osteoblast attachment to the entire LumiVy implant surface.
 
NanoVy Ti coating is high-adhesion and impact-resistant, and bonds intimately to the PEEK structure. It’s been shown, according to the company, to boost the implant’s expulsion resistance. It also does this without compromising radiolucency of the PEEK material.
 
LumiVy NanoVy lumbar IBF comes in an array of footprints for “nearly any” lumbar interbody approach. It’s also available in a range of sizes, heights, and lordotic angles.

Add us as a preferred source on Google

Get the latest Orthopedic Design & Technology news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters